GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sangui Biotech International Inc (OTCPK:SGBI) » Definitions » Cyclically Adjusted PB Ratio

Sangui Biotech International (Sangui Biotech International) Cyclically Adjusted PB Ratio : (As of Apr. 27, 2024)


View and export this data going back to . Start your Free Trial

What is Sangui Biotech International Cyclically Adjusted PB Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Sangui Biotech International Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Sangui Biotech International's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sangui Biotech International Cyclically Adjusted PB Ratio Chart

Sangui Biotech International Annual Data
Trend Jun13 Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 9.84 - - 6.28 3.55

Sangui Biotech International Quarterly Data
Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.12 3.55 4.45 2.08 2.78

Competitive Comparison of Sangui Biotech International's Cyclically Adjusted PB Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Sangui Biotech International's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sangui Biotech International's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Sangui Biotech International's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Sangui Biotech International's Cyclically Adjusted PB Ratio falls into.



Sangui Biotech International Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Sangui Biotech International's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2023 is calculated as:

For example, Sangui Biotech International's adjusted Book Value per Share data for the three months ended in Mar. 2023 was:

Adj_Book=Book Value per Share/CPI of Mar. 2023 (Change)*Current CPI (Mar. 2023)
=-0.002/122.4024*122.4024
=-0.002

Current CPI (Mar. 2023) = 122.4024.

Sangui Biotech International Quarterly Data

Book Value per Share CPI Adj_Book
201306 0.005 98.516 0.006
201309 0.007 98.983 0.009
201312 0.006 99.356 0.007
201403 0.003 99.543 0.004
201406 0.004 99.543 0.005
201409 0.003 99.823 0.004
201412 0.003 99.543 0.004
201503 0.002 99.717 0.002
201506 0.002 100.417 0.002
201509 0.001 100.417 0.001
201512 0.002 99.717 0.002
201603 0.002 100.017 0.002
201606 0.002 100.717 0.002
201609 0.002 101.017 0.002
201612 0.002 101.217 0.002
201703 0.002 101.417 0.002
201706 0.002 102.117 0.002
201709 0.002 102.717 0.002
201712 0.002 102.617 0.002
201803 0.001 102.917 0.001
201806 0.001 104.017 0.001
201809 0.001 104.718 0.001
201812 0.001 104.217 0.001
201903 0.001 104.217 0.001
201906 0.000 105.718 0.000
201909 0.000 106.018 0.000
201912 0.000 105.818 0.000
202003 0.000 105.718 0.000
202006 0.000 106.618 0.000
202009 -0.001 105.818 -0.001
202012 -0.001 105.518 -0.001
202103 -0.001 107.518 -0.001
202106 -0.001 108.486 -0.001
202109 -0.001 109.435 -0.001
202112 -0.001 110.384 -0.001
202203 -0.001 113.968 -0.001
202206 -0.001 115.760 -0.001
202209 -0.001 118.818 -0.001
202212 -0.002 119.345 -0.002
202303 -0.002 122.402 -0.002

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Sangui Biotech International  (OTCPK:SGBI) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Sangui Biotech International Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Sangui Biotech International's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Sangui Biotech International (Sangui Biotech International) Business Description

Traded in Other Exchanges
Address
Bleichenbrucke 9, Hamburg, DEU, 20354
Sangui Biotech International Inc develops pharmaceutical, medical and cosmetic products, through its subsidiary. The company develops oxygen carriers for providing oxygen transport in humans due to acute or chronic lack of oxygen and in the case of chronic wounds. It has also developed external applications of oxygen transporters in the form of sprays for healing chronic wounds and gels and emulsions for the regeneration of the skin. The products offered are artificial oxygen carriers; Chitoskin wound pads; and haemoglobin-based wound spray technology sold under the brand name Granulox. It derives revenue from licensing fees on sales of its wound spray product.
Executives
Hubertus Schmelz director NEUER WALL 54, HAMBURG 2M D-20354
Joachim Fleing director ALFRED HERRHAUSENSTR 44, WITTEN 2M 58455
Thomas Striepe director NEUER WALL 54, HAMBURG 2M D-20354
Wolfgang Barnikol director ALFRED HERRHAUSEN STR 44, WITTEN 2M 58455
Lutz Joachim director ALFRED-HERRHAUSEN-ST. 44, WITTEN 2M 58455
Christoph Ludz director SANDERSKOPPEL 17, HAMBURG 2M 22391

Sangui Biotech International (Sangui Biotech International) Headlines

No Headlines